Efficacy and safety of low, standard, and high dosages of an estradiol transdermal system (Esclim) compared with placebo on vasomotor symptoms in highly symptomatic menopausal patients

This publication has 16 references indexed in Scilit:

• Comparison of two estradiol transdermal systems (Oesclim® 50 and Estraderm TTS® 50). I. Tolerability, adhesion and efficacy
  Maturitas, 1996
• Comparison of two estradiol transdermal systems (Oesclim® 50 and estraderm TTS® 50). II. Local skin tolerability
  Maturitas, 1996
• Efficacy and tolerability of transdermal 17 beta-estradiol in patients with climacteric symptoms: dose titration according to individual choice
  Current Therapeutic Research, 1996
• A Double-Blind, Double-Dummy, Comparative Study of Menorest 50® versus Premarin® 0.625mg in the Treatment of Menopausal Symptoms and the Prevention of Bone Loss in Patients with Menopausal Symptoms
  Clinical Drug Investigation, 1996
• Efficacy and tolerability of Menorest® 50 compared with estraderm® TTS 50 in the treatment of postmenopausal symptoms. A randomized, multicenter, parallel group study
  Maturitas, 1995
• Long-term effects of transdermal and oral hormone replacement therapy on postmenopausal bone loss
  Osteoporosis International, 1994
• Acceptability and skin reactions to transdermal estrogen replacement therapy in relation to climate
  Maturitas, 1994
• Preventive effects of transdermal 17β-estradiol on osteoporotic changes after surgical menopause: A two-year placebo-controlled trial
  American Journal of Obstetrics and Gynecology, 1993
• Postmenopausal Estrogen Therapy and Cardiovascular Disease
  New England Journal of Medicine, 1991
• The relationship between plasma estradiol and the increase in bone density in postmenopausal women after treatment with subcutaneous hormone implants
  American Journal of Obstetrics and Gynecology, 1990